Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA: 688076)
China flag China · Delayed Price · Currency is CNY
61.65
-0.79 (-1.27%)
Oct 10, 2024, 3:00 PM CST

Jiangsu Sinopep-Allsino Biopharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
13,0979,5834,8908,811--
Upgrade
Market Cap Growth
120.01%95.95%-44.50%---
Upgrade
Enterprise Value
13,5319,7724,7268,238--
Upgrade
Last Close Price
59.5944.5822.6340.53--
Upgrade
PE Ratio
38.0258.6637.0967.56--
Upgrade
PS Ratio
8.839.277.5113.68--
Upgrade
PB Ratio
5.354.382.544.87--
Upgrade
P/FCF Ratio
-45.67-30.87-11.95-167.48--
Upgrade
P/OCF Ratio
44.4027.36166.9548.75--
Upgrade
EV/Sales Ratio
9.249.457.2612.79--
Upgrade
EV/EBITDA Ratio
24.0630.3127.7241.45--
Upgrade
EV/EBIT Ratio
34.2051.1565.8470.35--
Upgrade
EV/FCF Ratio
-37.03-31.48-11.55-156.58--
Upgrade
Debt / Equity Ratio
0.470.410.170.050.260.24
Upgrade
Debt / EBITDA Ratio
2.042.741.860.411.232.20
Upgrade
Debt / FCF Ratio
-3.14-2.88-0.78-1.598.24-0.89
Upgrade
Asset Turnover
0.440.340.280.370.430.32
Upgrade
Inventory Turnover
1.411.271.071.411.661.68
Upgrade
Quick Ratio
0.981.081.262.990.690.43
Upgrade
Current Ratio
1.371.541.914.011.280.88
Upgrade
Return on Equity (ROE)
16.45%8.04%6.58%7.84%13.30%5.52%
Upgrade
Return on Assets (ROA)
7.46%3.93%1.93%4.16%6.22%2.83%
Upgrade
Return on Capital (ROIC)
8.34%4.48%2.17%4.71%7.28%3.37%
Upgrade
Earnings Yield
2.63%1.70%2.64%1.31%--
Upgrade
FCF Yield
-2.79%-3.24%-8.36%-0.60%--
Upgrade
Dividend Yield
0.32%0.90%0.88%0.37%--
Upgrade
Payout Ratio
30.10%35.36%31.43%5.24%-22.43%
Upgrade
Buyback Yield / Dilution
-7.13%-1.29%-10.05%-19.96%1.06%-18.09%
Upgrade
Total Shareholder Return
-6.81%-0.40%-9.17%-19.59%1.06%-18.09%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.